Hyperelongated biglycan: the surreptitious initiator of atherosclerosis
To outline a role for the dermatan sulfate proteoglycan biglycan and specifically its growth factor modified form having elongated glycosaminoglycan chains as being a primary initiator of atherosclerosis. Antiatherosclerotic therapies have mostly targeted epidemiologically identified, experimentally...
Saved in:
Published in | Current opinion in lipidology Vol. 19; no. 5; p. 448 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
01.10.2008
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!